Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's Disease

Affiliations

¹ *Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastro Entérologie, Clermont-Ferrand, France †Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France ‡Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Radiologie, Clermont-Ferrand, France §Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri.

Anthony Buisson et al. Inflamm Bowel Dis. 2017 Sep.

. 2017 Sep;23(9):E44-E45.

doi: 10.1097/MIB.0000000000001219.

¹ *Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastro Entérologie, Clermont-Ferrand, France †Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France ‡Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Radiologie, Clermont-Ferrand, France §Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri.

No abstract available

Comment in

Reply.
Fernandes SR, Rodrigues RV, Bernardo S, Cortez-Pinto J, Rosa I, Pereira da Silva J, Gonçalves AR, Valente A, Baldaia C, Moura Santos P, Correia LA, Venâncio J, Campos P, Dias Pereira A, Velosa J. Fernandes SR, et al. Inflamm Bowel Dis. 2017 Sep;23(9):E45-E46. doi: 10.1097/MIB.0000000000001227. Inflamm Bowel Dis. 2017. PMID: 28786869 No abstract available.